Buchumschlag

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer: the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)

Weitere Versionen anzeigen (1)
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Minckwitz, Gunter von (VerfasserIn) , Rezai, Mahdi (VerfasserIn) , Tesch, Hans (VerfasserIn) , Huober, Jens (VerfasserIn) , Gerber, Bernd (VerfasserIn) , Zahm, Dirk M. (VerfasserIn) , Hilfrich, Jörn (VerfasserIn) , Costa, Serban Dan (VerfasserIn) , Dubsky, Peter (VerfasserIn) , Blohmer, Jens-Uwe (VerfasserIn) , Denkert, Carsten (VerfasserIn) , Hanusch, Claus Alexander (VerfasserIn) , Jackisch, Christian (VerfasserIn) , Kümmel, Sherko (VerfasserIn) , Fasching, Peter Andreas (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Paepke, Stefan (VerfasserIn) , Untch, Michael (VerfasserIn) , Burchardi, Nicole Diana (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: The European journal of cancer
Year: 2016, Jahrgang: 64, Pages: 12-21
ISSN:0959-8049
Online-Zugang: Volltext
Verfasserangaben:G. von Minckwitz, M. Rezai, H. Tesch, J. Huober, B. Gerber, D.M. Zahm, J. Hilfrich, S.D. Costa, P. Dubsky, J.U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, S. Kümmel, P.A. Fasching, A. Schneeweiss, S. Paepke, M. Untch, N. Burchardi, K. Mehta, S. Loibl for the German Breast Group and Austrian Breast and ColonCancer Study Group Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 866896864
003 DE-627
005 20230427061206.0
007 tu
008 160902s2016 xx ||||| 00| ||eng c
035 |a (DE-627)866896864 
035 |a (DE-576)9866896862 
035 |a (DE-599)GBV866896864 
035 |a (OCoLC)1340145379 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Minckwitz, Gunter von  |d 1964-  |e VerfasserIn  |0 (DE-588)172260035  |0 (DE-627)673296962  |0 (DE-576)133128202  |4 aut 
245 1 0 |a Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer  |b the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)  |c G. von Minckwitz, M. Rezai, H. Tesch, J. Huober, B. Gerber, D.M. Zahm, J. Hilfrich, S.D. Costa, P. Dubsky, J.U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, S. Kümmel, P.A. Fasching, A. Schneeweiss, S. Paepke, M. Untch, N. Burchardi, K. Mehta, S. Loibl for the German Breast Group and Austrian Breast and ColonCancer Study Group Investigators 
264 1 |c 2016 
300 |b Diagramme 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a Rezai, Mahdi  |d 1953-  |e VerfasserIn  |0 (DE-588)1107970350  |0 (DE-627)863713580  |0 (DE-576)475152131  |4 aut 
700 1 |a Tesch, Hans  |e VerfasserIn  |0 (DE-588)1020286687  |0 (DE-627)688112129  |0 (DE-576)360062873  |4 aut 
700 1 |a Huober, Jens  |e VerfasserIn  |0 (DE-588)1059154676  |0 (DE-627)798048239  |0 (DE-576)415183898  |4 aut 
700 1 |a Gerber, Bernd  |d 1957-  |e VerfasserIn  |0 (DE-588)136713238  |0 (DE-627)585337608  |0 (DE-576)301234620  |4 aut 
700 1 |a Zahm, Dirk M.  |e VerfasserIn  |4 aut 
700 1 |a Hilfrich, Jörn  |e VerfasserIn  |4 aut 
700 1 |a Costa, Serban Dan  |e VerfasserIn  |4 aut 
700 1 |a Dubsky, Peter  |e VerfasserIn  |4 aut 
700 1 |a Blohmer, Jens-Uwe  |d 1962-  |e VerfasserIn  |0 (DE-588)122376641  |0 (DE-627)081907958  |0 (DE-576)293244227  |4 aut 
700 1 |a Denkert, Carsten  |d 1969-  |e VerfasserIn  |0 (DE-588)118129929  |0 (DE-627)079261124  |0 (DE-576)291730604  |4 aut 
700 1 |a Hanusch, Claus Alexander  |d 1972-  |e VerfasserIn  |0 (DE-588)130827525  |0 (DE-627)506018563  |0 (DE-576)298362279  |4 aut 
700 1 |a Jackisch, Christian  |d 1960-  |e VerfasserIn  |0 (DE-588)1024193160  |0 (DE-627)71932730X  |0 (DE-576)368124908  |4 aut 
700 1 |a Kümmel, Sherko  |d 1971-  |e VerfasserIn  |0 (DE-588)122704142  |0 (DE-627)082103372  |0 (DE-576)293388016  |4 aut 
700 1 |a Fasching, Peter Andreas  |d 1975-  |e VerfasserIn  |0 (DE-588)129068780  |0 (DE-627)388703040  |0 (DE-576)297477099  |4 aut 
700 1 |a Schneeweiss, Andreas  |d 1961-  |e VerfasserIn  |0 (DE-588)109972554  |0 (DE-627)632849630  |0 (DE-576)327251859  |4 aut 
700 1 |a Paepke, Stefan  |d 1964-  |e VerfasserIn  |0 (DE-588)17293639X  |0 (DE-627)697863484  |0 (DE-576)133790584  |4 aut 
700 1 |a Untch, Michael  |e VerfasserIn  |0 (DE-588)134268083  |0 (DE-627)566077914  |0 (DE-576)300413572  |4 aut 
700 1 |a Burchardi, Nicole Diana  |d 1970-  |e VerfasserIn  |0 (DE-588)130244295  |0 (DE-627)495827657  |0 (DE-576)298084368  |4 aut 
773 0 8 |i Enthalten in  |t The European journal of cancer  |d Amsterdam [u.a.] : Elsevier, 1965  |g 64(2016), Seite 12-21  |w (DE-627)129271497  |w (DE-600)82061-1  |w (DE-576)014462206  |x 0959-8049  |7 nnas  |a Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29) 
773 1 8 |g volume:64  |g year:2016  |g pages:12-21  |a Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29) 
776 0 8 |i Erscheint auch als  |n Online-Ausgabe  |a Minckwitz, Gunter von, 1964 -   |t Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer  |d 2016  |w (DE-627)1570057788  |w (DE-576)500057788 
951 |a AR 
992 |a 20200817 
993 |a Article 
998 |g 109972554  |a Schneeweiss, Andreas  |m 109972554:Schneeweiss, Andreas  |d 910000  |d 910400  |e 910000PS109972554  |e 910400PS109972554  |k 0/910000/  |k 1/910000/910400/  |p 16 
999 |a KXP-PPN866896864  |e 3740496371 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer","title":"Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer","subtitle":"the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)"}],"person":[{"display":"Minckwitz, Gunter von","family":"Minckwitz","given":"Gunter von","role":"aut"},{"display":"Rezai, Mahdi","family":"Rezai","given":"Mahdi","role":"aut"},{"display":"Tesch, Hans","given":"Hans","role":"aut","family":"Tesch"},{"display":"Huober, Jens","family":"Huober","role":"aut","given":"Jens"},{"role":"aut","given":"Bernd","family":"Gerber","display":"Gerber, Bernd"},{"family":"Zahm","given":"Dirk M.","role":"aut","display":"Zahm, Dirk M."},{"display":"Hilfrich, Jörn","family":"Hilfrich","role":"aut","given":"Jörn"},{"display":"Costa, Serban Dan","given":"Serban Dan","role":"aut","family":"Costa"},{"role":"aut","given":"Peter","family":"Dubsky","display":"Dubsky, Peter"},{"role":"aut","given":"Jens-Uwe","family":"Blohmer","display":"Blohmer, Jens-Uwe"},{"display":"Denkert, Carsten","family":"Denkert","given":"Carsten","role":"aut"},{"given":"Claus Alexander","role":"aut","family":"Hanusch","display":"Hanusch, Claus Alexander"},{"family":"Jackisch","role":"aut","given":"Christian","display":"Jackisch, Christian"},{"display":"Kümmel, Sherko","family":"Kümmel","given":"Sherko","role":"aut"},{"role":"aut","given":"Peter Andreas","family":"Fasching","display":"Fasching, Peter Andreas"},{"family":"Schneeweiss","given":"Andreas","role":"aut","display":"Schneeweiss, Andreas"},{"role":"aut","given":"Stefan","family":"Paepke","display":"Paepke, Stefan"},{"display":"Untch, Michael","family":"Untch","given":"Michael","role":"aut"},{"given":"Nicole Diana","role":"aut","family":"Burchardi","display":"Burchardi, Nicole Diana"}],"type":{"bibl":"article-journal"},"physDesc":[{"noteIll":"Diagramme"}],"language":["eng"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"id":{"eki":["866896864"]},"relHost":[{"corporate":[{"role":"isb","display":"European Organization for Research on Treatment of Cancer"},{"role":"isb","display":"European Association for Cancer Research"},{"role":"isb","display":"European School of Oncology"}],"type":{"bibl":"periodical"},"language":["eng"],"titleTranslated":[{"translated":"Journal européen de cancérologie"},{"translated":"Europäische Zeitschrift für Cancerologie"}],"title":[{"title_sort":"European journal of cancer","subtitle":"EJC ; the official journal of EORTC, European Organization for Research and Treatment of Cancer, ESO, European School of Oncology, EACR, European Association for Cancer Research, FECS, Federation of European Cancer Societies = Journal européen de cancérologie = Europäische Zeitschrift für Cancerologie","title":"The European journal of cancer"}],"recId":"129271497","disp":"Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer the Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)The European journal of cancer","origin":[{"publisherPlace":"Amsterdam [u.a.] ; Oxford [u.a.] ; Frankfurt, M.","dateIssuedDisp":"1965-","publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1965"}],"id":{"zdb":["82061-1"],"issn":["0959-8049","0014-2964"],"eki":["129271497"]},"titleAlt":[{"title":"EJC"},{"title":"Europäische Zeitschrift für Cancerologie"},{"title":"Journal européen de cancérolgie"},{"title":"European journal of cancer"}],"note":["Parallelsacht. entfällt ab 7.1971","Repr.: Oxford : Pergamon Press"],"pubHistory":["1.1965 - 17.1981,6; 26.1990 - 28.1992,2/3; 33.1997 -"],"part":{"year":"2016","text":"64(2016), Seite 12-21","volume":"64","pages":"12-21"}}],"recId":"866896864","name":{"displayForm":["G. von Minckwitz, M. Rezai, H. Tesch, J. Huober, B. Gerber, D.M. Zahm, J. Hilfrich, S.D. Costa, P. Dubsky, J.U. Blohmer, C. Denkert, C. Hanusch, C. Jackisch, S. Kümmel, P.A. Fasching, A. Schneeweiss, S. Paepke, M. Untch, N. Burchardi, K. Mehta, S. Loibl for the German Breast Group and Austrian Breast and ColonCancer Study Group Investigators"]}} 
SRT |a MINCKWITZGZOLEDRONAT2016 

Ähnliche Einträge